Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
T cell-driven inflammation plays a critical role in the initiation and progression of atherosclerosis. The co-inhibitory protein Cytotoxic T-Lymphocyte Associated protein (CTLA) 4 is an important negative regulator of T cell activation. Here, we studied the effects of the antibody-mediated inhibitio...
Main Authors: | Kikkie Poels, Mandy M. T. van Leent, Myrthe E. Reiche, Pascal J. H. Kusters, Stephan Huveneers, Menno P. J. de Winther, Willem J. M. Mulder, Esther Lutgens, Tom T. P. Seijkens |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/9/1987 |
Similar Items
-
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01) -
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
by: Esther Lutgens, et al.
Published: (2021-06-01) -
Immuno-PET Imaging of Atherosclerotic Plaques with [<sup>89</sup>Zr]Zr-Anti-CD40 mAb—Proof of Concept
by: Kikkie Poels, et al.
Published: (2022-03-01) -
CTLA-4 Expression Plays a Role in PSC and PBC Progression
by: Phil Meister, et al.
Published: (2020-06-01) -
Inhibition of CTLA-4 accelerates atherosclerosis in hyperlipidemic mice by modulating the Th1/Th2 balance via the NF-κB signaling pathway
by: Ming-Luan Zhao, et al.
Published: (2024-09-01)